Transfusion and Apheresis Science
Volume 35, Issue 2 , Pages 97-102 , October 2006

Release of PMN elastase, TGF-β1 and neopterin during blood storage; unfiltered versus filtered blood

Received 1 November 2005 ,Accepted 6 June 2006.

References 

  1. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Brit J Surg. 1998;85:171–178
  2. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion. 2001;41:691–712
  3. Fergusson D, Herbert PC, Lee SK, Walker CR, Barrington KJ, Josef L, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941–1949
  4. Hyllner M, Arnestad JP, Bengtson JP, Rydberg L, Bengtsson A. Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion. 1997;37:264–268
  5. Kristiansson M, Soop M, Saraste L, Sundqvist KG. Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors. J Trauma. 1996;40:379–383
  6. Dzik S, Mincheff M, Puppo F. Apoptosis, transforming growth factor-β, and the immunosuppressive effect of transfusion. Transfusion. 2002;42:1221–1223
  7. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang. 1998;74(Suppl. 2):189–200
  8. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998;199:265–285
  9. Kalechman Y, Gafter U, Sobelman D, Sredni B. The effect of a single whole blood transfusion on cytokine secretion. J Clin Immunol. 1990;10:99–105
  10. Wadhwa M, Krailadsiri P, Dilger P, Gaines D, Seghatchian MJ, Thorpe R. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Vox Sang. 2002;83:125–136
  11. Uhlmann EJ, Isgriggs E, Wallermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion. 2001;41:997–1000
  12. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion. 2002;42:556–566
  13. Kristiansson M, Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions?. Acta Anaesthesiol Scand. 1996;40:496–501
  14. Hyllner M, Tylman M, Bengtson JP, Bengtsson A. Complement activation in prestorage leucocyte-filtered plasma. Transfus Med. 2004;14:45–52
  15. Ertel W, Jarrar D, Jochum M, Thiele V, Kenny J, Faist E, et al. Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis. Arch Surg. 1994;129:90–97
  16. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1–6
  17. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand. 2002;46:398–404
  18. Plata-Nazar K, Kozielska E, Luczak G. Clinical value of neopterin Part I. Med Wieku Rozwoj. 2004;VIII(2Pt2):433–437
  19. Wahl S, McCartney-Francis N, Alles J, Dougherty E, Dougherty S. Macrophage production of TGF-β and regulation by TGF-β. Ann NY Acad Sci. 1990;593:188–196
  20. Wahl SM. TGF-β in the evolution and resolution of inflammatory and immune processes. Microbes Infect. 1999;1:1247–1249
  21. Kunz D, Luley C, Heim MU, Bock M. Transforming growth factor-β is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion. 1998;38:156–159
  22. Mynster T, Dybkjoer E, Kronborg G, Nielsen HJ. Immunomodulating effect of blood transfusion: is storage time important?. Vox Sang. 1998;74:176–181
  23. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas D. Effect of transforming growth factor-β on early and late activation events in human T cells. J Immunol. 1993;150:3109–3118
  24. Frabetti F, Musiani D, Marini M, Fanelli C, Coppola S, Ghibelli L, et al. White cell apoptosis in packed red cells. Transfusion. 1998;38:1082–1089
  25. Nguyen LT, Ramanathan M, Weinstock-Guttman B, Baier M, Brownscheidle C, Jacobs LD. Sex differences in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J Neurol Sci. 2003;209(1–2):93–99
  26. Grainger DJ. Transforming growth factor-β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol. 2004;24:399–404
  27. Ivanovic V, Todorovic-Rakovic N, Demajo M, Neskovic-Konstantinovic Z, Subota V, Ivanisevic-Milovanovic O, et al. Elevated plasma levels of transforming growth factor-β 1 (TGF-β 1) in patients with advanced breast cancer: association with disease progression. Eur J Cancer. 2003;39:454–461

PII: S1473-0502(06)00116-9

doi: 10.1016/j.transci.2006.06.002

Transfusion and Apheresis Science
Volume 35, Issue 2 , Pages 97-102 , October 2006

Article Tools